New hope for schizophrenia: phase 3 drug trial begins
NCT ID NCT07363577
First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 2 times
Summary
This study tests a new drug, LB 102, to see if it helps reduce schizophrenia symptoms better than a placebo. About 456 adults with acute schizophrenia will take either the drug or a placebo for 6 weeks while staying in the hospital. The main goal is to measure changes in symptoms using a standard rating scale.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Accelerated Clinical Trial
RECRUITINGSnellville, Georgia, 30078, United States
-
Arch Clinical Trials
RECRUITINGSt Louis, Missouri, 63141, United States
-
CenExel
RECRUITINGGarden Grove, California, 92845, United States
-
Clinical Innovations, Inc.
RECRUITINGRiverside, California, 92506, United States
Contact Email: •••••@•••••
-
Health Synergy Clinical Research
RECRUITINGBoynton Beach, Florida, 33426, United States
-
Innovative Clinical Research
RECRUITINGMiami Lakes, Florida, 33016, United States
-
Neuro-Behavioral Clinical Research
RECRUITINGNorth Canton, Ohio, 44720, United States
-
Pillar Clinical Research
RECRUITINGBentonville, Arkansas, 72712, United States
Contact Email: •••••@•••••
-
Pillar Clinical Research
RECRUITINGLittle Rock, Arkansas, 72204, United States
Contact Email: •••••@•••••
-
Pillar Clinical Research
RECRUITINGChicago, Illinois, 60641, United States
Contact Email: •••••@•••••
-
ProScience Research Group
RECRUITINGCulver City, California, 90230, United States
-
Synergy San Diego
RECRUITINGLemon Grove, California, 92064, United States
-
Woodland International Research Group
RECRUITINGLittle Rock, Arkansas, 72211, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill for schizophrenia pass its first human test?
- Can a new daily pill offer safer Long-Term control of schizophrenia?
- Can an Anti-Seizure drug quiet the brain and sharpen thinking in schizophrenia?
- Can a dissolving film tame agitation in schizophrenia?
- Can a phone app teach the brain to read social cues?
- Can a gentle brain current silence voices that medication Can't?